Development Level

Tbio 26 | 10,625
Tchem 18 | 1,890
Tclin 4 | 602

IMPC Term

abnormal behavior 3 | 226
abnormal bone structure 2 | 131
abnormal eye morphology 2 | 38
increased circulating triglyce... 2 | 24
increased hematocrit 2 | 36
abnormal bone mineralization 1 | 55
abnormal coat/hair pigmentatio... 1 | 54
abnormal eye posterior chamber... 1 | 3
abnormal gait 1 | 51
abnormal iris morphology 1 | 12
abnormal lens morphology 1 | 73
abnormal locomotor activation 1 | 26
abnormal retina morphology 1 | 100
cataract 1 | 26
decreased bone mineral content 1 | 157
decreased cardiac output 1 | 2
decreased caudal vertebrae num... 1 | 49
decreased circulating alkaline... 1 | 41
decreased circulating amylase ... 1 | 24
decreased erythrocyte cell num... 1 | 43
decreased fasted circulating g... 1 | 49
decreased heart weight 1 | 44
decreased hemoglobin content 1 | 53
decreased lean body mass 1 | 195
decreased leukocyte cell numbe... 1 | 54
decreased lymphocyte cell numb... 1 | 9
decreased neutrophil cell numb... 1 | 37
decreased total body fat amoun... 1 | 186
decreased vertical activity 1 | 22
embryonic lethality prior to t... 1 | 187
enlarged heart 1 | 111
enlarged spleen 1 | 26
hypoactivity 1 | 89
increased bone mineral content 1 | 92
increased circulating alkaline... 1 | 119
increased circulating iron lev... 1 | 25
increased erythrocyte cell num... 1 | 26
increased hemoglobin content 1 | 45
increased mean corpuscular hem... 1 | 93
increased mean corpuscular vol... 1 | 91
increased sacral vertebrae num... 1 | 62
irregularly shaped pupil 1 | 7
preweaning lethality, complete... 1 | 633
preweaning lethality, incomple... 1 | 260
thin ventricular wall 1 | 5

Disease

ovarian cancer 31 | 8,492
osteosarcoma 30 | 7,933
psoriasis 29 | 6,685
medulloblastoma, large-cell 27 | 6,234
glioblastoma 26 | 5,572
atypical teratoid / rhabdoid tumor 23 | 4,369
lung cancer 19 | 4,473
oligodendroglioma 19 | 2,849
primitive neuroectodermal tumor 19 | 3,031
Cancer 18 | 2,346
invasive ductal carcinoma 16 | 2,950
astrocytic glioma 15 | 2,241
lung adenocarcinoma 15 | 2,714
ependymoma 14 | 2,514
group 3 medulloblastoma 13 | 2,254
intraductal papillary-mucinous adenoma (IPMA) 13 | 2,956
intraductal papillary-mucinous neoplasm (IPMN) 13 | 3,289
breast carcinoma 12 | 1,614
ductal carcinoma in situ 12 | 1,745
intraductal papillary-mucinous carcinoma (IPMC) 12 | 2,988
non-small cell lung cancer 12 | 2,798
pediatric high grade glioma 12 | 2,712
Breast cancer 11 | 3,099
adult high grade glioma 11 | 2,148
colon cancer 11 | 1,475
malignant mesothelioma 11 | 3,163
Carcinoma 10 | 2,147
Pick disease 10 | 1,893
ulcerative colitis 10 | 2,087
adrenocortical carcinoma 9 | 1,427
pancreatic cancer 9 | 2,300
pilocytic astrocytoma 9 | 3,086
group 4 medulloblastoma 8 | 1,875
spina bifida 8 | 1,064
subependymal giant cell astrocytoma 8 | 2,287
Bipolar Disorder 7 | 266
Multiple myeloma 7 | 1,328
Obesity 7 | 616
Waldenstrons macroglobulinemia 7 | 765
astrocytoma 7 | 1,493
diabetes mellitus 7 | 1,663
lung carcinoma 7 | 2,844
medulloblastoma 7 | 1,524
pancreatic ductal adenocarcinoma liver metastasis 7 | 1,795
pituitary cancer 7 | 1,972
posterior fossa group A ependymoma 7 | 1,511
tuberculosis 7 | 1,563
cutaneous lupus erythematosus 6 | 1,056
interstitial cystitis 6 | 2,299
nasopharyngeal carcinoma 6 | 1,056
Intellectual disability 5 | 573
Metabolic syndrome X 5 | 155
Seasonal affective disorder 5 | 25
aldosterone-producing adenoma 5 | 664
atypical teratoid/rhabdoid tumor 5 | 1,095
posterior fossa group B ependymoma 5 | 1,530
Asthma 4 | 349
Atopic dermatitis 4 | 944
Autistic Disorder 4 | 320
Diabetes Mellitus, Non-Insulin-Dependent 4 | 161
Drug-Induced Liver Injury 4 | 118
Endometriosis 4 | 535
Fatty liver disease 4 | 86
Heart disease 4 | 279
Hyperglycemia 4 | 120
Insulin Resistance 4 | 50
Myeloid Leukemia, Chronic 4 | 22
Parkinson's disease 4 | 364
Prostatic Neoplasms 4 | 471
Reperfusion Injury 4 | 84
Substance Withdrawal Syndrome 4 | 55
acute quadriplegic myopathy 4 | 1,157
chronic rhinosinusitis 4 | 512
esophageal adenocarcinoma 4 | 737
primary Sjogren syndrome 4 | 789
sonic hedgehog group medulloblastoma 4 | 1,482
Acquired metabolic disease 3 | 267
Alzheimer's disease 3 | 644
Atherosclerosis 3 | 275
Cerebrovascular disease 3 | 231
Diabetes Mellitus, Experimental 3 | 106
Epilepsy 3 | 346
Hypertension 3 | 293
IGA Glomerulonephritis 3 | 454
Lipid metabolism disorder 3 | 102
Major Depressive Disorder 3 | 106
Myocardial Infarction 3 | 126
Prader-Willi syndrome 3 | 45
Renal Cell Carcinoma 3 | 199
Schizophrenia 3 | 503
Small cell carcinoma of lung 3 | 45
Stomach Neoplasms 3 | 282
Toxic encephalopathy 3 | 131
Type 2 diabetes mellitus 3 | 192
active Crohn's disease 3 | 918
acute myeloid leukemia 3 | 785
cystic fibrosis 3 | 1,670
dermatomyositis 3 | 967
interstitial lung disease 3 | 292
juvenile dermatomyositis 3 | 1,189

Tissue

Blood and immune system 48 | 17,995
Cardiovascular System 48 | 17,958
Digestive Tract 48 | 18,473
Endocrine System 48 | 18,512
Female tissues 48 | 18,647
Liver and Pancreas 48 | 18,136
Male tissues 48 | 17,969
Nervous System 48 | 18,561
Respiratory system 48 | 17,484
Skin and soft tissues 48 | 18,115
Urinary Tract 48 | 18,444

Target Family

Non-IDG 17 | 11,969
Kinase 10 | 634
Enzyme 6 | 4,146
Nuclear Receptor 6 | 48
Transcription Factor 5 | 1,400
GPCR 3 | 408
Epigenetic 1 | 242

GO Process

regulation of circadian rhythm 48 | 48
transcription, DNA-templated 1,779 | 1,779
regulation of transcription, D... 1,170 | 1,170
signal transduction 969 | 969
positive regulation of transcr... 845 | 845
G-protein coupled receptor sig... 666 | 666
negative regulation of transcr... 620 | 620
apoptotic process 506 | 506
positive regulation of transcr... 504 | 504
negative regulation of transcr... 483 | 483
multicellular organism develop... 456 | 456
positive regulation of cell pr... 451 | 451
cell differentiation 442 | 442
negative regulation of apoptot... 440 | 440
innate immune response 410 | 410
cell adhesion 409 | 409
immune response 398 | 398
negative regulation of cell pr... 379 | 379
inflammatory response 371 | 371
viral process 368 | 368
spermatogenesis 365 | 365
cell proliferation 358 | 358
protein transport 356 | 356
intracellular signal transduct... 355 | 355
cell division 330 | 330
regulation of transcription fr... 324 | 324
protein phosphorylation 320 | 320
response to drug 297 | 297
positive regulation of apoptot... 292 | 292
nervous system development 275 | 275
transcription from RNA polymer... 272 | 272
cell surface receptor signalin... 267 | 267
protein ubiquitination 260 | 260
transport 257 | 257
cell-cell signaling 249 | 249
regulation of immune response 247 | 247
positive regulation of gene ex... 242 | 242
mitotic nuclear division 241 | 241
MAPK cascade 238 | 238
chemical synaptic transmission 238 | 238
mRNA splicing, via spliceosome 219 | 219
angiogenesis 218 | 218
small GTPase mediated signal t... 215 | 215
translation 215 | 215
rRNA processing 209 | 209
intracellular protein transpor... 205 | 205
cellular response to DNA damag... 201 | 201
cell cycle 200 | 200
proteasome-mediated ubiquitin-... 200 | 200
proteolysis 199 | 199
visual perception 198 | 198
DNA repair 196 | 196
extracellular matrix organizat... 193 | 193
regulation of apoptotic proces... 190 | 190
brain development 183 | 183
positive regulation of cell mi... 181 | 181
protein polyubiquitination 181 | 181
in utero embryonic development 178 | 178
Fc-epsilon receptor signaling ... 176 | 176
Wnt signaling pathway 175 | 175
ion transmembrane transport 174 | 174
protein homooligomerization 173 | 173
heart development 170 | 170
positive regulation of ERK1 an... 170 | 170
blood coagulation 169 | 169
cell migration 168 | 168
regulation of cell proliferati... 167 | 167
protein autophosphorylation 166 | 166
response to hypoxia 164 | 164
mRNA processing 162 | 162
negative regulation of canonic... 162 | 162
protein folding 162 | 162
T cell receptor signaling path... 161 | 161
response to lipopolysaccharide 161 | 161
defense response to virus 160 | 160
RNA splicing 158 | 158
aging 158 | 158
positive regulation of I-kappa... 158 | 158
axon guidance 157 | 157
homophilic cell adhesion via p... 155 | 155
sensory perception of smell 155 | 155
ER to Golgi vesicle-mediated t... 151 | 151
interferon-gamma-mediated sign... 150 | 150
protein ubiquitination involve... 150 | 150
transcription initiation from ... 150 | 150
ubiquitin-dependent protein ca... 149 | 149
DNA replication 144 | 144
adaptive immune response 139 | 139
cell cycle arrest 139 | 139
receptor-mediated endocytosis 139 | 139
skeletal system development 136 | 136
regulation of cell shape 135 | 135
regulation of small GTPase med... 134 | 134
G2/M transition of mitotic cel... 133 | 133
oxidation-reduction process 133 | 133
positive regulation of cytosol... 133 | 133
protein stabilization 133 | 133
sensory perception of sound 132 | 132
positive regulation of NF-kapp... 131 | 131
antigen processing and present... 130 | 130
type I interferon signaling pa... 130 | 130

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Melanopsin OPN4 Tbio GPCR -2.73085 537.3 58
Serine/threonine-protein phosphatase PP1-alpha catalytic subunit PPP1CA Tchem Enzyme -2.15861 136.6 346
Serine/threonine-protein phosphatase PP1-beta catalytic subunit PPP1CB Tbio Enzyme -1.52305 32.4 306
Paraspeckle component 1 PSPC1 Tbio Non-IDG -1.71804 43.5 20
Melanoma-associated antigen D1 MAGED1 Tbio Non-IDG -1.52430 43.4 211
Nocturnin NOCT Tbio Non-IDG -1.81437 34.3 83
5'-AMP-activated protein kinase catalytic subunit alpha-2 PRKAA2 Tchem Kinase -1.34127 18.6 546
MAGE-like protein 2 MAGEL2 Tbio Non-IDG -1.88169 71.2 75
Nuclear receptor subfamily 1 group D member 2 NR1D2 Tbio Nuclear Receptor -1.70951 50.9 178
F-box/LRR-repeat protein 3 FBXL3 Tbio Non-IDG -0.94799 9.59 158